EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Effect of Skeletal Muscle Mass and Its Associated Mediators on the Development of Steatotic Liver Disease: A Cohort Study in China

Yebei Liang, Rong Yu, Xiaoqi Ye, Lu Yang, Fusong Jiang, Liang Feng, Lichang Zhong, Keqing Dong, Li Wei, Yuqian Bao, Xuhong Hou, Weiping Jia iD

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.70093 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Yebei Liang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Department of Endocrinology and Metabolism, Shanghai Clinical Center for D…. Hauptthemen laut MEDLINE: Muscle, Skeletal, Fatty Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Innovation 2030, Major Project-Research on Cancer, Cardiovascular, Respiratory and Metabolic Diseases, Shenzhen Medical Research Fund, Shanghai Research Center for Endocrine and Metabolic Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Understanding the relationship between relative skeletal muscle mass and newly proposed steatotic liver disease (SLD) is crucial, but research gaps still exist. Based on a cohort study, we investigated the impact of relative skeletal muscle mass on incident SLD and its subtypes and explored potential mediators involved in these relationships.

Methods

We followed 1964 subjects aged 55–70 years (median age: 61.4 [58.4–65.1] years; 45.5% male participants). Appendicular skeletal muscle mass (ASM) was measured using bioelectrical impedance analysis and adjusted for height squared (ASM/height 2 ), weight (ASM/weight) and body mass index (ASM/BMI) to quantify relative skeletal muscle mass. SLD was diagnosed using ultrasonography and classified into metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol‐associated liver disease (MetALD) and alcohol‐associated liver disease (ALD).

Results

Over a mean 4.3‐year follow‐up period, 598 participants (30.4%) developed SLD: 539 MASLD (27.4%), 38 MetALD (1.9%) and 21 ALD (1.1%). Higher ASM/weight and ASM/BMI were associated with lower risks of SLD and MASLD (RR per SD [95% CI]: 0.71 [0.61–0.82], 0.59 [0.46–0.76]; 0.66 [0.58–0.76], 0.51 [0.40–0.64]; all p < 0.001). Associations of ASM/height 2 with SLD and MASLD shifted from positive to negative after adjustment for BMI (from 1.67 [1.51–1.84] to 0.77 [0.67–0.89]; from 2.30 [1.92–2.76] to 0.61 [0.47–0.79], all p < 0.001). ASM/height 2 and ASM/weight were negatively associated with MetALD (0.49 [0.26–0.94], p = 0.031; 0.50 [0.27–0.93], p = 0.029), whereas ASM/BMI was inversely associated with ALD (0.40 [0.18–0.88], p = 0.023). The effects of ASM/height 2 , ASM/weight and ASM/BMI on incident MASLD were partially mediated by adiponectin (percentage mediated [95% CI]: 6.3% [2.5%–11.1%]; 9.4% [5.0%–14.6%]; 9.5% [5.1%–15.5%]), uric acid (4.7% [1.6%–8.9%]; 5.3% [2.6%–8.5%]; 5.3% [2.4%–8.8%]), triglyceride (7.1% [3.9%–11.1%]; 7.5% [4.4%–10.9%]; 8.7% [5.3%–13.4%]) and homeostasis model assessment of insulin resistance (13.9% [9.5%–20.4%]; 15.0% [10.0%–20.2%]; 14.5% [9.9%–20.7%]). The effects of ASM/weight and ASM/BMI on incident MASLD were mediated by cholinesterase (8.2% [3.6%–13.1%]; 10.5% [6.1%–16.3%]), prealbumin (6.2% [2.9%–9.8%]; 6.0% [3.0%–10.1%]), retinol‐binding protein‐4 (5.4% [3.0%–8.5%]; 4.6% [1.9%–8.5%]) and osteocalcin (2.1% [0.1%–4.5%]; 2.9% [0.6%–5.7%]).

Conclusions

Relative skeletal muscle mass adjusted for weight or BMI, rather than height alone, better reflects protective effects against SLD. Mediation analysis reveals key metabolic factors linking muscle mass and liver health, offering insights into the pathogenic pathways involved in muscle–liver crosstalk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle, SkeletalFatty LiverHumansMaleMiddle AgedFemaleAgedChinaCohort StudiesBody Mass Index

Stichwörter der Autor:innen

appendicular skeletal muscle masscommunity‐based prospective cohort studymediatorsmetabolic dysfunction and alcohol‐associated liver diseasemetabolic dysfunction–associated steatotic liver disease

Autor:innen und Institutionen

  • Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai…
  • Department of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Specialized Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Ultrasound in Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • General Practitioner Teams in Community Health Service Center of Nicheng, Pudong New District, Shanghai, China.

ORCID-Profile: Weiping Jia

Förderung

  • National Science and Technology Innovation 2030, Major Project-Research on Cancer, Cardiovascular, Respiratory and Metabolic Diseases
  • Shenzhen Medical Research Fund
  • Shanghai Research Center for Endocrine and Metabolic Diseases
  • National Key Clinical Specialty
  • Fujian Provincial Finance Project
  • Sichuan Science and Technology Program
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Liang, Y., Yu, R., Ye, X., Yang, L., Jiang, F., Feng, L., Zhong, L., Dong, K., Wei, L., Bao, Y., Hou, X., & Jia, W. (2025). Effect of Skeletal Muscle Mass and Its Associated Mediators on the Development of Steatotic Liver Disease: A Cohort Study in China. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70093

Vancouver

Liang Y, Yu R, Ye X, Yang L, Jiang F, Feng L, et al. Effect of Skeletal Muscle Mass and Its Associated Mediators on the Development of Steatotic Liver Disease: A Cohort Study in China. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.70093

BibTeX
@article{Liang2025,
  author = {Liang, Yebei and Yu, Rong and Ye, Xiaoqi and Yang, Lu and Jiang, Fusong and Feng, Liang and Zhong, Lichang and Dong, Keqing and Wei, Li and Bao, Yuqian and Hou, Xuhong and Jia, Weiping},
  title = {Effect of Skeletal Muscle Mass and Its Associated Mediators on the Development of Steatotic Liver Disease: A Cohort Study in China},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.70093}
}
Kostenlos starten →